Patents by Inventor Meir Haber

Meir Haber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220257527
    Abstract: Disclosed herein are orally administrable mucoadhesive film compositions which comprise a poorly water soluble bioactive material(s) in a high loading, an alginate as a major film-forming polymer, and an emulsifier. Also provided is a method for preparing such films, including the step of homogenizing a composition comprising these components.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventors: Meir HABER, David GABBAY, Revital MASHAL, Michal SANCHIK
  • Patent number: 8840935
    Abstract: The invention relates to an orally administrable mucoadhesive film which comprises one or more bioactive ingredients and, as a major film-forming polymer, at least one alginate which is capable of forming a low viscosity aqueous solution. Also provided is a process for preparing such films.
    Type: Grant
    Filed: April 30, 2007
    Date of Patent: September 23, 2014
    Assignee: Biota Ltd.
    Inventors: Meir Haber, Thordis Kristmundsdottir, Skuli Skulason
  • Patent number: 8703117
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: April 22, 2014
    Assignee: Lifebond Ltd.
    Inventors: Orahn Preiss Bloom, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • Patent number: 8367388
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: February 5, 2013
    Assignee: Lifebond Ltd.
    Inventors: Orahn Preiss Bloom, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • Publication number: 20120329132
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Application
    Filed: July 23, 2012
    Publication date: December 27, 2012
    Inventors: Orahn Preiss BLOOM, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • Publication number: 20110110882
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Application
    Filed: June 18, 2009
    Publication date: May 12, 2011
    Inventors: Orahn Preiss-Bloom, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • Publication number: 20090186107
    Abstract: The invention relates to an orally administrable mucoadhesive film which comprises one or more bioactive ingredients and, as a major film-forming polymer, at least one alginate which is capable of forming a low viscosity aqueous solution. Also provided is a process for preparing such films.
    Type: Application
    Filed: April 30, 2007
    Publication date: July 23, 2009
    Inventors: Meir Haber, Thordis Kristmundsdottir, Skuli Skulason
  • Patent number: 5859198
    Abstract: Adhesive proteins isolated from mature plants selected from the group consisting of macroalgae and microalgae, said proteins being characterized by the presence of at least one RGD or RGD-like or other adhesive recognition sequence, the absence of DOPA and hydroxyproline units, and by the fact that the proteins may be used by the plants in their natural state, for the purpose of adhesion to substrates.
    Type: Grant
    Filed: August 31, 1995
    Date of Patent: January 12, 1999
    Inventor: Meir Haber